地域連携感染制御学講座
緑膿菌感染症研究会
第50回緑膿菌感染症研究会
第7回私立医科大学病院感染対策協議会
第22回マクロライド新作用研究会
研究室メンバー専用

お問い合わせ・連絡先

東邦大学 医学部
微生物・感染症学講座
(医学部 1号館 9階)

〒143-8540
東京都大田区大森西5-21-16
TEL 03-3762-4151

2004年

No. 著者名 演題名 掲載誌名 ページ
1 Miyazaki S, Okazaki K, Tsuji M and Yamaguchi K Pharmacodynamics of S-3578, a novel cephem, in murine lung and systemic infection models Antimicrob Agents Chemother 48 378-383 2004
2 Matsumoto T, Nieuwenhuis EE, Cisneros RL, Ruiz-Perez B, Yamaguchi K, Blumberg RS and Onderdonk AB Protective effect of ethyl-3-(3-dimethyl aminopropyl) urea dihydrochloride (EDU) against LPS-induced death in mice J Med Microbiol 53 97-102 2004
3 Kodaka K, Uesaka Y and Kashitani F Nissui glucose fermentative gram-negative rod identification system EB-20 gives a unique profile for typical nonsorbitol fermenting Escherichia coli O157:H7 J Clin Microbiol 42 354-358 2004
4 Miyazaki S, Ishikawa F, Fujikawa T, Nagata S and Yamaguchi K Intaraperitoneal injection of lipopolysaccharide induces dynamic migration of Gr1high polymophonuclear neutrophils in the murine abdominal cavity Clin Diagn Lab Immunol 11 452-457 2004
5 Tateda K, Standiford TJ, Pechere JC and Yamaguchi K Regulatory effects of macrolides on bacterial virulence:Potential role as quorum-sensing inhibitors Current Pharmaceutical Design 10 3055-3065 2004
6 Nara C, Tateda K, Matsumoto T, Ohara A, Miyazaki S, Standiford TJ and Yamaguchi K Legionella-induced acute lung injury in the setting of hyperoxia: protective role of tumour necrosis factor-alpha J Med Microbiol 53 1-7 2004
7 Kimura S, Ishiguro M, Ishii Y, Alba J and Yamaguchi K Role of a mutational substitution at position 167 of CTXM-19 in ceftazidime hydrolysis Antimicrob Agents Chemother 48 1454-1460 2004
8 Suzuki K, Matsumoto T, Murakami H, Tateda K, Ishii N and Yamaguchi K Evaluation of a rapid antigen detection test for Neisseria gonorrhoeae in urine sediment for diagnosis of gonococcal urethritis in males J Infect Chemother 10 208-211 2004
9 Ma L, Alba J, Chang FY, Ishiguro M, Yamaguchi K, Siu LK and Ishii Y Novel SHV-derived extended-spectrum β-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin Antimicrob Agents Chemother 2 600-605 2004
10 Miyashita N, Yamaguchi K, Saito A, Kohno S, Watanabe A, Oda H, Kazuyama Y and Matsushima T Multiplex PCR for the simultaneous detection of Chlamydia pneumoniae, Mycoplasma pneumoniae and Legionella pneumophila in community-acquired pneumonia Resp Med 98 542-550 2004
11 Kobayashi I, Yamaguchi K, Muraoka H, Iyoda T, Nishida M and Hasegawa M Antimicrobial susceptibility testing of vancomycin-resistant Enterococcus by the VITEK2 system and comparison with two NCCLS reference methods J Med Microbiol 53 1229-1232 2004
12 Yoshizumi S, Takahashi Y, Watanabe Y, Okezaki E, Ishii Y and Tateda K In vitro antibacterial activities of new fluoroquinolones against clinical isolates of Haemophilus influenzae with ciprofloxacin-resistance-associated alterations in GyrA and ParC Chemotherapy 50 265-275 2004
13 Tsai WC, Rodriguez ML, Young KS, Deng JC, Thannickal VJ, Tateda K, Hershenson MB and Standiford TJ Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection Am J. Respir Crit Care Med 170 1331-1339 2004
14 Ohno N, Fukuda H, Kimura S, Kim HW, Takahashi H, Amachi S, Shinoyama H and Fujii T Purification and properties of xylan degrading enzymes produced by Penicillium expansum O-385-10 concerning spoilage of apple fruit Jpn J Food Micribiol 21 260-268 2004
15 Miyazaki S Optimization of dose and dose regimen of biapenem based on pharmacokinetic and pharmacodynamic analysis J Infect Chemother 10 135 2004